Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

FRA:KIN2 - Deutsche Boerse Ag - CA4969024047 - Common Stock - Currency: EUR

13.18  -0.06 (-0.49%)

Fundamental Rating

6

Overall KIN2 gets a fundamental rating of 6 out of 10. We evaluated KIN2 against 39 industry peers in the Metals & Mining industry. KIN2 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. KIN2 is not valued too expensively and it also shows a decent growth rate. These ratings could make KIN2 a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

KIN2 had positive earnings in the past year.
KIN2 had a positive operating cash flow in the past year.
KIN2 had positive earnings in 4 of the past 5 years.
KIN2 had a positive operating cash flow in each of the past 5 years.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 8.73%, KIN2 belongs to the top of the industry, outperforming 87.18% of the companies in the same industry.
KIN2's Return On Equity of 13.83% is amongst the best of the industry. KIN2 outperforms 82.05% of its industry peers.
The Return On Invested Capital of KIN2 (9.40%) is better than 82.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN2 is in line with the industry average of 7.17%.
The last Return On Invested Capital (9.40%) for KIN2 is above the 3 year average (6.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROIC 9.4%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

KIN2 has a Profit Margin of 18.43%. This is amongst the best in the industry. KIN2 outperforms 87.18% of its industry peers.
KIN2's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 28.48%, KIN2 belongs to the best of the industry, outperforming 89.74% of the companies in the same industry.
In the last couple of years the Operating Margin of KIN2 has grown nicely.
KIN2 has a Gross Margin of 35.04%. This is in the better half of the industry: KIN2 outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of KIN2 has grown nicely.
Industry RankSector Rank
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

KIN2 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KIN2 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KIN2 has less shares outstanding
KIN2 has a better debt/assets ratio than last year.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

KIN2 has an Altman-Z score of 2.79. This is not the best score and indicates that KIN2 is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, KIN2 is in the better half of the industry, outperforming 79.49% of the companies in the same industry.
KIN2 has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
The Debt to FCF ratio of KIN2 (1.05) is better than 94.87% of its industry peers.
KIN2 has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
KIN2 has a better Debt to Equity ratio (0.18) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Altman-Z 2.79
ROIC/WACC1.21
WACC7.78%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that KIN2 has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.01, KIN2 is doing good in the industry, outperforming 74.36% of the companies in the same industry.
A Quick Ratio of 0.83 indicates that KIN2 may have some problems paying its short term obligations.
KIN2 has a Quick ratio of 0.83. This is comparable to the rest of the industry: KIN2 outperforms 41.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

KIN2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.23%, which is quite impressive.
The Earnings Per Share has been growing by 14.87% on average over the past years. This is quite good.
The Revenue has grown by 26.71% in the past year. This is a very strong growth!
The Revenue has been growing by 8.04% on average over the past years. This is quite good.
EPS 1Y (TTM)87.23%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%200%
Revenue 1Y (TTM)26.71%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%38.47%

3.2 Future

KIN2 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.95% yearly.
Based on estimates for the next years, KIN2 will show a decrease in Revenue. The Revenue will decrease by -1.05% on average per year.
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y5.95%
Revenue Next Year16.44%
Revenue Next 2Y9.09%
Revenue Next 3Y5.54%
Revenue Next 5Y-1.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.34, which indicates a rather expensive current valuation of KIN2.
KIN2's Price/Earnings ratio is in line with the industry average.
KIN2 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.38 indicates a correct valuation of KIN2.
KIN2's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.29. KIN2 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.34
Fwd PE 15.38
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

KIN2's Enterprise Value to EBITDA is on the same level as the industry average.
KIN2's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN2 is cheaper than 87.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.68
EV/EBITDA 7.49
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN2 has an outstanding profitability rating, which may justify a higher PE ratio.
KIN2's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)1.17
EPS Next 2Y20.9%
EPS Next 3Y14.28%

2

5. Dividend

5.1 Amount

KIN2 has a yearly dividend return of 0.78%, which is pretty low.
Compared to an average industry Dividend Yield of 3.24, KIN2 has a dividend in line with its industry peers.
With a Dividend Yield of 0.78, KIN2 pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 0.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

KIN2 pays out 15.55% of its income as dividend. This is a sustainable payout ratio.
DP15.55%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (6/25/2025, 7:00:00 PM)

13.18

-0.06 (-0.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-30 2025-07-30
Inst Owners68.33%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap16.17B
Analysts80
Price Target17.07 (29.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP15.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-18.81%
Max EPS beat(2)25.89%
EPS beat(4)3
Avg EPS beat(4)16.49%
Min EPS beat(4)-18.81%
Max EPS beat(4)57.06%
EPS beat(8)7
Avg EPS beat(8)29.26%
EPS beat(12)8
Avg EPS beat(12)13.27%
EPS beat(16)10
Avg EPS beat(16)12.49%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.08%
PT rev (3m)27.84%
EPS NQ rev (1m)1.39%
EPS NQ rev (3m)13.05%
EPS NY rev (1m)0%
EPS NY rev (3m)13.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.99%
Valuation
Industry RankSector Rank
PE 17.34
Fwd PE 15.38
P/S 3.64
P/FCF 13.68
P/OCF 7.67
P/B 2.73
P/tB 2.73
EV/EBITDA 7.49
EPS(TTM)0.76
EY5.77%
EPS(NY)0.86
Fwd EY6.5%
FCF(TTM)0.96
FCFY7.31%
OCF(TTM)1.72
OCFY13.05%
SpS3.62
BVpS4.82
TBVpS4.82
PEG (NY)0.43
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROCE 14.95%
ROIC 9.4%
ROICexc 10.02%
ROICexgc 10.02%
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
FCFM 26.63%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
ROICexc(3y)6.62%
ROICexc(5y)7.08%
ROICexgc(3y)6.62%
ROICexgc(5y)7.14%
ROCE(3y)9.92%
ROCE(5y)10.4%
ROICexcg growth 3Y20.62%
ROICexcg growth 5Y13.48%
ROICexc growth 3Y21.33%
ROICexc growth 5Y13.94%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Debt/EBITDA 0.47
Cap/Depr 93.73%
Cap/Sales 20.89%
Interest Coverage 11.44
Cash Conversion 93.6%
Profit Quality 144.49%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 2.79
F-Score7
WACC7.78%
ROIC/WACC1.21
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.23%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%200%
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y5.95%
Revenue 1Y (TTM)26.71%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%38.47%
Revenue Next Year16.44%
Revenue Next 2Y9.09%
Revenue Next 3Y5.54%
Revenue Next 5Y-1.05%
EBIT growth 1Y74.49%
EBIT growth 3Y21.5%
EBIT growth 5Y17.5%
EBIT Next Year131.51%
EBIT Next 3Y30.48%
EBIT Next 5Y11.84%
FCF growth 1Y170.39%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y52.4%
OCF growth 3Y29.17%
OCF growth 5Y14.84%